Copyright © 2007
Connective Tissue Oncology Society

All Rights Reserved


2002 CTOS Annual Meeting Oral Presentations — Biology

DIFFERENTIAL GENE EXPRESSION IN LEIOMYOSARCOMA
[Abstract ID: 24]

Category: Biology

Presentation: Oral

Authors: Keith M Skubitz1, Amy P. Skubitz1

Author Institutions: 1University of Minnesota, MN, United States

Presenter: Keith M Skubitz
skubi001@tc.umn.edu

Correspondent: Keith M Skubitz
skubi001@tc.umn.edu
Minneapolis MN United States 55455
Ph: 612-625-5411
Fax: 612-626-1441


Objectives: Soft tissue sarcomas are a heterogeneous group of malignancies of mesenchymal origin, the causes of which are unclear. In this study gene expression in leiomyosarcomas, myometrium, and uterine leiomyomas was examined.

Methods: RNA was prepared and gene expression was determined at Gene Logic Inc. (Gaithersburg, MD) using Affymetrix GeneChip® U_95 arrays containing approximately 12,000 known genes and 48,000 ESTs. Gene expression analysis was performed with Gene Logic Gene Express® software. Differences in gene expression were quantified as the fold change in gene expression in leiomyosarcomas compared with normal myometrium, and uterine leiomyomas.

Results: A number of genes were differentially expressed in these sample sets, and these genes were analyzed for their expression in a variety of other normal and diseased tissues. Some of the genes identified were over-expressed only in leiomyosarcomas among the tissues examined, and some were over-expressed in other tissues as well

Conclusions: We conclude that differences in gene expression can be detected between leiomyosarcomas and uterine leiomyomas, and normal myometrium, and that these changes in gene expression may yield clues to the pathophysiology of this malignancy.


back next